Targeting fibroblast-like synoviocytes in rheumatoid arthritis
V Tsaltskan, GS Firestein - Current opinion in pharmacology, 2022 - Elsevier
Fibroblast-like synoviocytes (FLS) are mesenchymal-derived cells that play an important role
in the physiology of the synovium by producing certain components of the synovial fluid and …
in the physiology of the synovium by producing certain components of the synovial fluid and …
Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go?
Fibroblast-like synoviocytes or synovial fibroblasts (FLS) are important cellular components
of the inner layer of the joint capsule, referred to as the synovial membrane. They can be …
of the inner layer of the joint capsule, referred to as the synovial membrane. They can be …
[HTML][HTML] Synovial macrophage and fibroblast heterogeneity in joint homeostasis and inflammation
The synovial tissue is an immunologically challenging environment where, under
homeostatic conditions, highly specialized subsets of immune-regulatory macrophages and …
homeostatic conditions, highly specialized subsets of immune-regulatory macrophages and …
[HTML][HTML] Regulation of differentiation and generation of osteoclasts in rheumatoid arthritis
Q Niu, J Gao, L Wang, J Liu, L Zhang - Frontiers in Immunology, 2022 - frontiersin.org
Introduction Rheumatoid arthritis (RA), which affects nearly 1% of the world's population, is a
debilitating autoimmune disease. Bone erosion caused by periarticular osteopenia and …
debilitating autoimmune disease. Bone erosion caused by periarticular osteopenia and …
[HTML][HTML] The expression of inflammasomes NLRP1 and NLRP3, toll-like receptors, and vitamin D receptor in synovial fibroblasts from patients with different types of …
R Sakalyte, J Denkovskij, E Bernotiene… - Frontiers in …, 2022 - frontiersin.org
Activated rheumatoid arthritis (RA) synovial fibroblasts (SFs) are among the most important
cells promoting RA pathogenesis. They are considered active contributors to the initiation …
cells promoting RA pathogenesis. They are considered active contributors to the initiation …
Galectin‐3 facilitates inflammation and apoptosis in chondrocytes through upregulation of the TLR‐4‐mediated oxidative stress pathway in TC28a2 human …
WC Chou, KL Tsai, PL Hsieh, CH Wu… - Environmental …, 2022 - Wiley Online Library
Osteoarthritis (OA) is a common degenerative joint disease. The pathological changes of
chondrocytes involve oxidative stress, the pro‐inflammatory response, and pro‐apoptotic …
chondrocytes involve oxidative stress, the pro‐inflammatory response, and pro‐apoptotic …
[HTML][HTML] How pyroptosis contributes to inflammation and fibroblast-macrophage cross-talk in rheumatoid arthritis
About thirty years ago, a new form of pro-inflammatory lytic cell death was observed and
termed pyroptosis. Only in 2015, gasdermins were defined as molecules that create pores at …
termed pyroptosis. Only in 2015, gasdermins were defined as molecules that create pores at …
Acteoside promotes B cell-derived IL-10 production and ameliorates autoimmunity
Abstract IL-10-producing regulatory B (Breg) cells are well recognized for maintaining
immune tolerance. The impaired Breg cell function with decreased IL-10-producing capacity …
immune tolerance. The impaired Breg cell function with decreased IL-10-producing capacity …
[HTML][HTML] Host-pathogen protein-nucleic acid interactions: A comprehensive review
Recognition of pathogen-derived nucleic acids by host cells is an effective host strategy to
detect pathogenic invasion and trigger immune responses. In the context of pathogen …
detect pathogenic invasion and trigger immune responses. In the context of pathogen …
[HTML][HTML] Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications
Immunotherapy has reached clinical success in the last decade, with the emergence of new
and effective treatments such as checkpoint blockade therapy and CAR T-cell therapy that …
and effective treatments such as checkpoint blockade therapy and CAR T-cell therapy that …